Comparison of the 6th and 7th Editions of the American Joint Committee on Cancer Tumor-Node-Metastasis Staging System in Patients With Resected Esophageal Carcinoma

Annals of Thoracic Surgery

Volumn 89, Issue 4, 2010, Pages 1024-1031

  Hsu, Po Kuei ^a,b,c   Wu, Yu Chung ^b,c   Chou, Teh Ying ^b,c   Huang, Chien Sheng ^b,c   Hsu, Wen Hu ^b,c,d  

^a Chutung Veterans Hospital   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS;

EID: 77949719569     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2010.01.017     Document Type: Article

References (24)

1. Lin C.S., Chang S.C., Wei Y.H., et al. Prognostic variables in thoracic esophageal squamous cell carcinoma. Ann Thorac Surg 87 (2009) 1056-1065
2. Jemal A., Siegel R., Ward E., Hao Y., Xu J., and Thun M.L. Cancer statistics, 2009. CA Cancer J Clin 59 (2009) 225-249
3. National Comprehensive Cancer Network. Esophageal Cancer Clinical Practice Guidelines in OncologyV.1.2009. www.nccn.org
4. Greene F.L., Page D.L., Fleming I.D., et al. Esophagus. American Joint Committee on Cancer (AJCC) cancer staging manual. 6th ed. (2002), Springer, New York, NY 167-178
5. Rice T.W., Blacestone E.H., Rybicki L.A., et al. Refining esophageal cancer staging. J Thorac Cardiovasc Surg 125 (2003) 1103-1113
6. Hofstetter W., Correa A.M., Bekele N., et al. Proposed modification of nodal status in AJCC esophageal cancer staging system. Ann Thorac Surg 84 (2007) 365-375
7. Hsu W.H., Hsu P.K., Hsieh C.C., Huang C.S., and Wu Y.C. The metastatic lymph node number and ratio are independent prognostic factors in esophageal cancer. J Gastrointest Surg 13 (2009) 1913-1920
8. Rizk N., Venkatraman E., Park B., et al. The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system. J Thorac Cardiovasc Surg 132 (2006) 1374-1381
9. Edge S.B., Byrd D.R., Compton C.C., Fritz A.G., Greene F.L., and Trotti A. American Joint Committee on Cancer (AJCC) cancer staging manual. 7th ed. (2010), Springer, Inc, Chicago
10. Rice T.W., Rusch V.W., and Blackstone E.H. 2009 AJCC/UICC staging of esophageal cancer. In: Shields T.W., Locicero J., Reed C.E., and Feins R.H. (Eds). General thoracic surgery. 7th ed. Vol 2 (2009), Wolters Kluwer, Amsterdam 2013-2015
11. Ueno S., Tanabe G., Sako K., et al. Discrimination value of new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Hepatology 34 (2001) 529-534
12. Cho Y.K., Chung J.W., Kim J.K., et al. Comparison of 7 staging systems for patients with hepatocellular undergoing transarterial chemoembolization. Cancer 112 (2008) 352-361
13. Kee K.M., Wang J.H., Lee C.M., et al. Validation of clinical AJCC/UICC TNM staging system for hepatocellular carcinoma: analysis of 5163 cases from a medical center in southern Taiwan. Int J Cancer 120 (2007) 2650-2655
14. Jamieson G.G., Lamb P.J., and Thompson S.K. The role of lymphadenectomy in esophageal cancer. Ann Surg 250 (2009) 206-209
15. van Vliet E.P., Heijenbrok-Kal M.H., Hunink M.G., Kuipers E.J., and Siersema P.D. Staging investigations for oesophageal cancer: a meta-analysis. Br J Cancer 98 (2008) 547-557
16. Hsu W.H., Hsu P.K., Wang S.J., et al. Positron emission tomography-computed tomography in predicting locoregional invasion in esophageal squamous cell carcinoma. Ann Thorac Surg 87 (2009) 1564-1568
17. Dickson G.H., Singh K.K., Escofet X., and Kelly K. Validation of a modified GTNM classification in peri-junctional esophago-gastric carcinoma and its use as a prognostic indicator. Eur J Surg Oncol 27 (2001) 641-644
18. Altorki N., Zhou X.K., Stiles B., et al. Total number of resected lymph nodes predicts survival in esophageal cancer. Ann Surg 248 (2008) 221-226
19. Bogoevski D., Onken F., Koenig A., et al. Is it time for a new TNM classification in esophageal carcinoma?. Ann Surg 247 (2008) 633-641
20. Rice T.W., Rusch V.W., Apperson-Hansen C., et al. World esophageal cancer collaboration. Dis Esophagus 22 (2009) 1-8
21. Wijnhoven B.P.L., Tran K.T.C., Esterman A., Waston D.I., and Tilanus H.W. An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann Surg 245 (2007) 717-725
22. Roder J.D., Busch R., Stein H.J., Fink U., and Siewert J.R. Ratio of invaded to removed lymph nodes as a prognostic of survival in squamous cell carcinoma of the esophagus. Br J Surg 81 (1994) 410-413
23. Eloubeidi M., Desmond R., Arduedas M.R., Reed C.E., and Wilcox C.M. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S. Cancer 95 (2002) 1434-1443
24. Doki Y., Ishikawa O., Takachi K., et al. Association of the primary tumor location with the site of tumor recurrence after curative resection of thoracic esophageal carcinoma. World J Surg 29 (2005) 700-707